The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Kuopio Atherosclerosis Prevention Study (KAPS): A Population-Based Primary Preventive Trial of the Effect of LDL Lowering on Atherosclerotic Progression in Carotid and Femoral Arteries
Abstract
Background The atherosclerotic progression–reducing effect of LDL cholesterol (LDL-C) lowering has been established in subjects with severe atherosclerotic disease but not in persons with elevated LDL cholesterols without severe atherosclerosis. KAPS (Kuopio Atherosclerosis Prevention Study) is the first population-based trial in the primary prevention of carotid and femoral atherosclerosis. Methods and Results The eligibility requirements were serum LDL-C ≥4.0 mmol/L and total cholesterol <7.5 mmol/L. Out of a geographically defined population, 447 men aged 44 to 65 years (mean, 57) were randomized to pravastatin (40 mg/d) or placebo for 3 years. Less than 10% of the subjects had prior myocardial infarction. Thirty-nine men discontinued study medication; however, efficacy data were available for 424 men. The primary outcome was the rate of carotid atherosclerotic progression, measured as the linear slope over annual ultrasound examinations in the average of the maximum carotid intima-media thickness (IMT) of the far wall of up to four arterial segments (the right and left distal common carotid artery and the right and left carotid bulb). For the carotid arteries, at the overall mean baseline IMT of 1.66 mm, the rate of progression of carotid atherosclerosis was 45% (95% CI, 16 to 69%) less in the pravastatin (0.017 mm/y) than the placebo (0.031 mm/y) group ( P =.005). In the common carotid artery there was a treatment effect of 66% (95% CI, 30 to 95%; pravastatin 0.010 mm/y; placebo 0.029 mm/y; P <.002) at the overall mean baseline IMT of 1.35 mm. A treatment effect of 30% (95% CI, −1% to 54%) was found for the carotid bulb (pravastatin, 0.028; placebo, 0.040; P =.056) at the overall mean baseline IMT of 2.0 mm. The treatment effect was larger in subjects with higher baseline IMT values, in smokers and in those with low plasma vitamin E levels. There was no significant treatment effect on atherosclerotic progression in the femoral arteries. Conclusions These data establish the antiatherogenic effect of LDL-C lowering by pravastatin in hypercholesterolemic men in a primary prevention setting and suggest a greater effect in smokers than in nonsmokers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Statistical Method in Biological Assay.
Healy, M. J. R., & Finney, D. J. (1979) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982559 · Cited by 3,586
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Can lifestyle changes reverse coronary heart disease?
Ornish, D., Brown, S. E., Billings, J. H., Scherwitz, L. W., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Gould, K. L., & Brand, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91656-u · Cited by 2,338
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Blankenhorn, D. H. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390230069027 · Cited by 1,655
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Self-citationUltrasonographically assessed carotid morphology and the risk of coronary heart disease.
Salonen, J. T., & Salonen, R. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1245 · Cited by 911
Self-citationFurberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Kane, J. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450230043027 · Cited by 829
Ultrasound B-mode imaging in observational studies of atherosclerotic progression.
SALONEN, J. T., & Salonen, R. M. (1993) · PubMed · Cited by 783
Self-citationPravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
Crouse, J. R., Byington, R. P., Bond, M. G., Espefand, M. A., Craven, T. E., Sprinkle, J. W., McGovern, M. E., & Furberg, C. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80580-3 · Cited by 609
SALONEN, R., & SALONEN, J. T. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00336.x · Cited by 566
Self-citationCraven, T. E., Ryu, J. E., Espeland, M. A., Kahl, F. R., McKinney, W. M., Toole, J. F., McMahan, M. R., Thompson, C. J., Heiss, G., & Crouse, J. R. (1990) · Circulation · doi:10.1161/01.cir.82.4.1230 · Cited by 555
Salonen, R., & Salonen, J. T. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90056-o · Cited by 445
Self-citationLevy, R. I., Brensike, J. F., Epstein, S. E., Kelsey, S. F., Passamani, E. R., Richardson, J. M., Loh, I. K., Stone, N. J., Aldrich, R. F., & Battaglini, J. W. (1984) · Circulation · doi:10.1161/01.cir.69.2.325 · Cited by 437
Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement.
Finley, P. R., Schifman, R. B., Williams, R. J., & Lichti, D. A. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.931 · Cited by 418
Risk factors and atherosclerotic lesions. A review of autopsy studies
Solberg, L. A., & Strong, J. P. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.3.187 · Cited by 371
SALONEN, J. T. (1988) · PubMed · Cited by 347
Self-citationPrevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland.
Salonen, R., Seppänen, K., Rauramaa, R., & Salonen, J. T. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.6.788 · Cited by 315
Self-citationGeorge Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.
Blankenhorn, D. H., & Hodis, H. N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.177 · Cited by 224
Salonen, R., Haapanen, A., & Salonen, J. T. (1991) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(91)90043-v · Cited by 223
Self-citation(1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90858-a · Cited by 182
Crouse, J. R., Harpold, G. J., Kahl, F. R., Toole, J. F., & McKinney, W. M. (1986) · Stroke · doi:10.1161/01.str.17.2.270 · Cited by 157
Nyyssönen, K., Porkkala-Sarataho, E., Salonen, R. M., Korpela, H., & Salonen, J. T. (1994) · PubMed · Cited by 87
Self-citationWikstrand, J., & Wendelhag, I. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00845.x · Cited by 84
Pravastatin, lipids, and major coronary events
Furberg, C. D., Byington, R. P., Crouse, J. R., & Espeland, M. A. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90297-6 · Cited by 79
Salonen, J., Korpela, H., Salonen, R. M., & Nyyssönen, K. (1993) · The Lancet · doi:10.1016/0140-6736(93)93184-3 · Cited by 50
Self-citationRisk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men
Salonen, J. T., & Salonen, R. M. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00846.x · Cited by 38
Self-citation
Cited by
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Metadata
- Authors
- Salonen, R., Nyyssönen, K., Porkkala, E., Rummukainen, J., Belder, R., Park, J.-S., & Salonen, J. T.
- Venue
- Circulation
- Published
- 1995-10
- Volume
- 92
- Issue
- 7
- Pages
- 1758-1764
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2102006980
- Cited by
- 540
- References
- 30
- FWCI
- 29.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.